G-CREDIT (Gangnam-Cohort for Risk Evaluation of Diabetes and Impaired Glucose Tolerance)
15. april 2016 opdateret af: Yonsei University
The prevalence of type 2 diabetes has consistently increased and type 2 diabetes can cause many types of vascular complications.
Diabetes develops due to glucose intolerance.
Early detection and intervention in the stage of glucose intolerance makes it afford to prevent overt diabetes and its complications.
This study was designed to make a cohort of korean patients with glucose intolerance to construct a long term database about clinical characteristics of these patients.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Undersøgelsestype
Observationel
Tilmelding (Forventet)
500
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Chul Woo Ahn, MD
- Telefonnummer: 82-02-2019-3339
- E-mail: acw@yuhs.ac
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
20 år til 100 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Patients with either type 2 diabetes or impaired glucose toloerance who are older than 20 years old and have attended Gangnam Severance hospital for regular follow up.
Beskrivelse
Inclusion Criteria:
- Patients older than 20 years old who has visited Gangnam severance hospital since January 2007.
- Patients with either diabetes or impaired glucose tolerance
- Patients with at least 6 months of follow-up period
Exclusion Criteria:
1. Patients with gestational diabetes, any active stage of cancer and severe disability
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
Diabetes and Impaired glucose Tolerance (G-CREDIT)
Patients with either type 2 diabetes or impaired glucose tolerance who are older than 20 years old and have attended Gangnam Severance hospital for regular follow up.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Life style assessment - Past medical history - Smoking, alcohol history - Sleep, exercise, daily activity check - Diet - Reproductive status (Women only) - Socioeconomic status
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Past medical history
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Smoking, alcohol history
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Sleep, exercise, daily activity check
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Diet
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Reproductive status (Women only)
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Socioeconomic status
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Anthropometric measurements : Height, weight, waist circumference, pulse rate, blood pressure
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
SMA, TG, HDL, LDLM apoA, apoB
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
PC2hrs, HbA1C, Insulin, C-peptide (AC, PC2hr), hs-CRP
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Urine protein, albumin, creatinine
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
EKG, Neurometer, Chest PA, Abdominal sonography
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
Fundus photography, fat computed tomography
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
|
HOMA-IR, HOMA-β
Tidsramme: an expected average of 12 weeks
|
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
|
an expected average of 12 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. januar 2007
Primær færdiggørelse (Forventet)
1. februar 2026
Studieafslutning (Forventet)
1. februar 2026
Datoer for studieregistrering
Først indsendt
27. marts 2016
Først indsendt, der opfyldte QC-kriterier
27. marts 2016
Først opslået (Skøn)
1. april 2016
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
18. april 2016
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
15. april 2016
Sidst verificeret
1. april 2016
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 3-2010-0195
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-planbeskrivelse
This study has a plan to share data
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .